Athira pharma to present data from first-in-human phase 1 clinical trial of ath-1105 at the 4th annual als drug development summit

Data from phase 1 clinical trial of ath-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and cns penetration support continued clinical development

ATHA Ratings Summary

ATHA Quant Ranking